Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B cell scaffold protein with ankyrin repeats 1 (BANK1) is a B cell-specific adaptor protein that plays a critical role in integrating signals downstream of the B cell receptor (BCR) and Toll-like receptors (TLRs)[1][2][5][6]. It orchestrates BCR-induced calcium mobilization from intracellular stores and facilitates Lyn-mediated tyrosine phosphorylation of inositol 1,4,5-trisphosphate receptors[1][2][5][6]. BANK1 interacts with key signaling proteins (BLK, LYN, MyD88, TRAF6, PLCγ2), influencing cytokine production, cell activation, and the regulation of B cell memory responses[2][5]. Genetic variants in BANK1 alter its regulatory domains and expression, leading to increased risk for autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosis[2][5][6]. BANK1 is being explored as a biomarker in autoimmune conditions and cancer but is not yet a clinical therapeutic target[3][5][6].
Not applicable—no drugs directly modulate BANK1, but in principle, a drug targeting BANK1 could modulate B cell receptor signaling, calcium mobilization, cytokine production, and downstream adaptive immune responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B cell scaffold protein with ankyrin repeats 1 (BANK1).